Skip to Content

AngioSoma Inc SOAN

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

AngioSoma Inc is a US-based is a wellness company. Through its subsidiary, the company is dedicated to bringing innovative, effective, and high-quality supplement products for the medical, wellness, and adult-use markets. Its products comprise OmniCath I and II and Nutraceuticals.

2500 Wilcrest Drive, Suite 300, 3rd Floor
Houston, TX, 77042
T +1 832 781-8521
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Dec 31, 2020
Fiscal Year End Sep 30, 2021
Stock Type Distressed
Employees 1